HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts. The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries. It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage. The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe. In case of public companies, it focuses on those which originate from its private portfolio. The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company's IPO. It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company's Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives. The fund exits its portfolio companies through trade sale or IPO.

HBM Healthcare Investments AG

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

	Mar '14	Mar '15	Mar '16	Mar '17	Mar '18	Mar '19	Mar '20	Mar '21	Mar '22	Mar '23	Mar '24
net income	353.52M -	257.51M 27.16%	23.09M 91.03%	136.77M 492.37%	115.87M 15.28%	209.07M 80.43%	182.70M 12.61%	756.27M 313.95%	-78.03M 110.32%	-146.32M 87.51%	-1.08M 99.26%
depreciation and amortization
deferred income tax
stock based compensation
change in working capital
accounts receivables
inventory
accounts payables
other working capital
other non cash items	-353.52M -	-257.51M 27.16%	-23.09M 91.03%	-136.77M 492.37%	-115.87M 15.28%	-211.92M 82.89%	-186.86M 11.83%	-759.50M 306.46%	67.83M 108.93%	145.03M 113.80%	-622K 100.43%
net cash provided by operating activities	353.52M -	257.51M 27.16%	23.09M 91.03%	136.77M 492.37%	115.87M 15.28%	-2.85M 102.46%	-4.16M 45.79%	-3.23M 22.41%	-10.20M 216.09%	-1.29M 87.37%	-1.71M 32.38%
investments in property plant and equipment
acquisitions net
purchases of investments	-309.82M -	-323.26M 4.34%	-491.79M 52.13%
sales maturities of investments	332.01M -	516.94M 55.70%	503.65M 2.57%
other investing activites	20.57M -	13.78M 33.00%	62K 99.55%	80M 128,932.26%	60M 25%	52M 13.33%	60M 15.38%	59M 1.67%	50M 15.25%	71.50M 43%	125M 74.83%
net cash used for investing activites	42.76M -	207.46M 385.23%	11.92M 94.25%	80M 571.14%	60M 25%	52M 13.33%	60M 15.38%	59M 1.67%	50M 15.25%	71.50M 43%	125M 74.83%
debt repayment	-12.95M -	-284K 97.81%							-50M -		-50M -
common stock issued	7.94M -	17.40M 119.19%	30.02M 72.58%
common stock repurchased	-41.51M -	-96.30M 132.00%	-65.88M 31.58%	-36.48M 44.64%	-13.39M 63.30%	-10.44M 22.05%	-52.18M 400.03%	-53.57M 2.67%	-86.96M 62.34%	-67.48M 22.40%	-66.50M 1.46%
dividends paid	-12.95M -	-23.59M 82.17%	-42.27M 79.21%	-40.04M 5.28%	-40.78M 1.86%	-38.26M 6.18%
other financing activites	25.90M -	148K 99.43%	98.42M 66,403.38%	-2.26M 102.30%	-2.27M 0.62%	-2.27M 0.18%	-2.27M 0.13%	-2.27M 0.22%	96.52M 4,357.43%	-2.38M 102.47%	-2.30M 3.44%
net cash used provided by financing activities	-33.57M -	-102.62M 205.69%	20.29M 119.77%	-78.77M 488.18%	-56.44M 28.35%	-50.97M 9.70%	-54.45M 6.83%	-55.84M 2.55%	-40.45M 27.56%	-69.87M 72.74%	-118.80M 70.03%
effect of forex changes on cash	-764K -	4.66M 709.29%	-707K 115.19%	-3K 99.58%	-1K 66.67%	1K 200%	1K 0%
net change in cash	-5.20M -	93.89M 1,905.25%	-35.56M 137.87%	-491K 98.62%	407K 182.89%	-1.82M 546.93%	1.39M 176.58%	-63K 104.52%	-645K 923.81%	344K 153.33%	4.50M 1,206.69%
cash at beginning of period	51.69M -	46.49M 10.06%	140.38M 201.96%	6.61M 95.29%	6.12M 7.43%	6.52M 6.66%	4.70M 27.89%	6.10M 29.62%	6.03M 1.03%	5.39M 10.69%	5.73M 6.38%
cash at end of period	46.49M -	140.38M 201.96%	104.82M 25.33%	6.12M 94.17%	6.52M 6.66%	4.70M 27.89%	6.10M 29.62%	6.03M 1.03%	5.39M 10.69%	5.73M 6.38%	10.23M 78.42%
operating cash flow	353.52M -	257.51M 27.16%	23.09M 91.03%	136.77M 492.37%	115.87M 15.28%	-2.85M 102.46%	-4.16M 45.79%	-3.23M 22.41%	-10.20M 216.09%	-1.29M 87.37%	-1.71M 32.38%
capital expenditure
free cash flow	353.52M -	257.51M 27.16%	23.09M 91.03%	136.77M 492.37%	115.87M 15.28%	-2.85M 102.46%	-4.16M 45.79%	-3.23M 22.41%	-10.20M 216.09%	-1.29M 87.37%	-1.71M 32.38%

COM:HBMHEALTHCARE

Galecto, Inc.

Last Close

180.00

21/11 16:31

Market Cap

11.45M

Beta: -

Volume Today

4.93K

Avg: -

Preview